Current therapeutic options for brain ischemia

Neurology

Volumn 49, Issue 5 SUPPL., 1997, Pages

  Kaste, Markku ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; CALCIUM CHANNEL BLOCKING AGENT; FIBRINOLYTIC AGENT; STEROID;

ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; DECISION MAKING; EARLY DIAGNOSIS; HEALTH CARE QUALITY; HUMAN; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE;

EID: 0030724437     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.49.5_suppl_4.s56     Document Type: Article

References (16)

1. Kaste M, Palomaki H, Sarna S. Where and how should elderly stroke patients be treated? Stroke 1995;26:249-253.
2. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet 1993;342:395-398.
3. Aboderin I, Venables G, for the Pan European Consensus Meeting on Stroke Management. Stroke management in Europe J Intern Med 1996;240:173-180.
4. Adams HP, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke. A statement for health care professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:1901-1914.
5. Bogousslavsky J, Brott T, Diener H-C, et al. European strategies for early intervention in stroke. A report of an Ad Hoc Consensus Group Meeting. Cerebrovasc Dis 1996;6:315-324.
6. Adams HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for health care professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1996;27:1711-1718.
7. Easton JD, Hart RG, Sherman DG, Kaste M. Diagnosis and management of ischemic stroke 1 - threatened stroke and its management. Curr Probl Cardiol 1983;7:6-76.
8. Cerebral Embolism Task Force. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 1989;46:727-743.
9. Marsh EE III, Adams HP Jr, Biller J, et al. Use of antithrombotic drugs in the treatment of acute ischemic stroke. A survey of neurologists in practice in the United States. Neurology 1989;39:1631-1634.
10. Hacke W, Kaste M, Fieschi C, et al., for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274:1017-1025.
11. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
12. Diener H-C, Hacke W, Hennerici M, Radberg J, Hantson L, DeKeyser J. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Stroke 1996;27:76-81.
13. Kaste M. Early and late rehabilitation of stroke: current approaches including assessment of the quality of outcome. In: Harrison MA, ed. Physiotherapy in stroke management. Edinburgh: Churchill Livingstone, 1995:245-251.
14. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337:1235-1243.
15. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:81-106.
16. The European Atrial Fibrillation trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995;333:5-10.